Form 4: Jack Schuler Acquires 1,560,694 Units of Accelerate Diagnostics in Private Placement

Jack Schuler, a director and 10% owner of Accelerate Diagnostics, acquired 1,560,694 units, each consisting of one share of common stock and one warrant, in a private placement.

Summary

• On May 20, 2024, Jack Schuler acquired 1,560,694 units of Accelerate Diagnostics at $1.73 per unit.
• Each unit consists of one share of common stock and one warrant to purchase one share of common stock.
• The warrants have an exercise price of $1.65 and expire on January 23, 2029.
• Following the transaction, Schuler directly owns 7,594 shares and indirectly owns 8,510,388 shares through the Jack W. Schuler Living Trust.
• Schuler also indirectly owns 5,497 shares through his spouse, but disclaims beneficial ownership except to the extent of his pecuniary interest.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard disclosure of insider activity. The acquisition could be seen as a positive signal, but it's not overwhelmingly positive.

Positives

• The acquisition of units by a director and significant shareholder could be seen as a positive signal, indicating confidence in the company's future prospects.

Risks

• The document does not explicitly mention any risks.

Industry Context

Form 4 filings are standard disclosures for insiders buying or selling company stock, providing transparency to the market.

Stakeholder Impact

• The acquisition of shares by a director may increase investor confidence.

Key Dates